Lisa M. Doherty, RN, NP, OCN

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2009

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
March 2009 - December 2012
Glioma
Bevacizumab
Lbh589



